Discontinued — last reported Q4 '25
Accumulated Depreciation
Non-Current AssetsEli Lilly Accumulated Depreciation decreased by 1.1% to $12.41B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $11.82B to $12.41B. Over 4 years (FY 2020 to FY 2024), Accumulated Depreciation shows an upward trend with a 5.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
Parent metricPP&E (Net)
How to read this metric
A high ratio of accumulated depreciation to gross PP&E may indicate an aging asset base requiring future capital expenditure.
Detailed definition
This is the cumulative amount of depreciation expense charged against fixed assets since their acquisition. It represent...
Peer comparison
Standard accounting metric; essential for evaluating the lifecycle stage of industrial assets.
Metric ID:
ppe_accumulated_depreciationHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.84B | $9.96B | $9.98B | $10.14B | $10.12B | $10.07B | $10.23B | $10.49B | $10.63B | $10.77B | $11.10B | $11.24B | $11.43B | $11.82B | $11.79B | $12.15B | $12.55B | $12.41B |
| QoQ Change | — | +1.2% | +0.1% | +1.6% | -0.2% | -0.5% | +1.6% | +2.5% | +1.4% | +1.3% | +3.1% | +1.2% | +1.7% | +3.4% | -0.2% | +3.0% | +3.4% | -1.1% |
| YoY Change | — | — | — | — | +2.8% | +1.1% | +2.6% | +3.4% | +5.1% | +6.9% | +8.5% | +7.1% | +7.5% | +9.7% | +6.2% | +8.1% | +9.9% | +5.0% |
| % of PP&E (Net) | 111.1% | 111.7% | 111.0% | 111.4% | 110.9% | 108.2% | 100.9% | 99.4% | 94.3% | 90.8% | 86.0% | 82.5% | 77.1% | 73.1% | 68.9% | 65.8% | 61.2% | 55.6% |
| Share Change | — | +0.5pp | -0.6pp | +0.3pp | -0.5pp | -2.7pp | -7.3pp | -1.5pp | -5.2pp | -3.5pp | -4.8pp | -3.5pp | -5.4pp | -4.0pp | -4.1pp | -3.2pp | -4.6pp | -5.5pp |
Range$9.84B – $12.55B
CAGR+5.6%
Avg YoY Growth+6.0%
Median YoY Growth+6.6%
Accumulated Depreciation at Other Companies
Frequently Asked Questions
- What is Eli Lilly's accumulated depreciation?
- Eli Lilly (LLY) reported accumulated depreciation of $12.41B in Q3 2025.
- How has Eli Lilly's accumulated depreciation changed year-over-year?
- Eli Lilly's accumulated depreciation increased by 5.0% year-over-year, from $11.82B to $12.41B.
- What is the long-term trend for Eli Lilly's accumulated depreciation?
- Over 4 years (2020 to 2024), Eli Lilly's accumulated depreciation has grown at a 5.3% compound annual growth rate (CAGR), from $9.57B to $11.79B.
- What does accumulated depreciation mean?
- The total amount of depreciation recorded for all assets since they were purchased.